CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 18:32 Adaptive Sports (August 2019) 5 years ago For Teens & Adults,PPMD Adult Advisory Committee (PAAC) Webinars,Webinars 57:50 Capricor’s HOPE-2 Interim Analysis (July 2019) 5 years ago Research & Clinical Trial Webinars,Webinars 36:52 Rolling Around the World (June 2019) 6 years ago For Teens & Adults,PPMD Adult Advisory Committee (PAAC) Webinars,Webinars 56:20 Domagrozumab as a Potential Treatment for Duchenne (May 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 55:59 Santhera Update to the Duchenne Community (May 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 34:57 Capricor’s Clinical Program (April 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 48:55 Italfarmaco Provides Givinostat Update (March 2019) 6 years ago Research & Clinical Trial Webinars,Webinars 1:00:47 Caring for the Caregiver (February 2019) 6 years ago Care Webinars,Webinars «1…1314151617…25»Page 15 of 25
by: Parent Project Muscular Dystrophy
